Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1979-10-26
pubmed:abstractText
Phytohemagglutinin (PHA) or concanavalin A treatment of lymphocytes causes an increase in membrane permeability so that the leak rates of Na and K increase 1.5- to 2-fold. Active Na and K transport increase proportionately in response to the increased membrane permeability. We have examined the role of lymphocyte Na concentration in sustaining the increased Na and K transport observed after PHA treatment. Cell Na concentration increases from 14.8 to 20.5 mmol/liter cell water in PHA-treated lymphocytes (P < 0.001). Four lines of evidence suggest that the 5-6 mmol/liter cell water increase in lymphocyte Na accounts for the increase in active Na and K transport in mitogen-treated lymphocytes. First, PHA does not increase directly the maximal Na, K-ATPase activity of isolated lymphocyte membrane vesicles. Second, when the Na concentration is increased by 6 mmol/liter cell water in unstimulated lymphocytes, Na and K transport increase nearly twofold. Third, the cell Na concentration (15 mmol/liter cell water) is near the K(m) for Na activation of the Na, K-ATPase in lymphocyte membranes. The ATPase activity thus, is capable of increasing as the cell Na rises above normal. Fourth, if lymphocytes are incubated in a medium containing a low Na concentration, K transport does not maintain the internal K concentration and the fall in cell K is accentuated in PHA-treated lymphocytes. These studies indicate that the adaptive acceleration of Na and K transport in mitogen-treated lymphocytes is mediated by a small increase in cell Na.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-1082887, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-1085774, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-123786, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-1238407, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-125654, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-1262405, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-13445725, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-224068, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-4720935, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-4974753, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-5496279, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-6065891, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-631216, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-730777, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-82969, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-890573, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-982538, http://linkedlifedata.com/resource/pubmed/commentcorrection/224078-993349
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
834-41
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1979
pubmed:articleTitle
Regulation of sodium and potassium transport in phytohemagglutinin-stimulated human blood lymphocytes.
pubmed:publicationType
Journal Article, Comparative Study, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.